MolecularMD develops and commercializes specialty molecular diagnostics for oncology applications. Its tests are designed to allow appropriate selection, monitoring and management of patients treated with molecularly-targeted cancer therapies. MolecularMD integrates gold standard and innovative platform technologies with custom clinical assay design and validation to accelerate all phases of clinical development.
The thirteenth PMWC offers exhibition options for emerging and established companies and organizations to promote their products and services. This is an opportunity for exhibitors to interact with PMWC participants actively involved and leading the personalized medicine revolution.
PMWC 2018 Exhibitors
Exhibitions are open January 22-24 from 7:30am – 5:30pm each day. The busiest times are during designated breaks:
10:00am – 10:30am
3:30pm – 4:00pm